Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/spie/radiogenomics-in-brain-breast-and-lung-cancer-opportunities-and-pwoy9NkqYC
References (142)
-
(ObeidJ.-P.et al., “Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat,” Clin. Transl. Oncol. 19(2), 211–218 (2017).10.1007/s12094-016-1526-927364695)
ObeidJ.-P.et al., “Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat,” Clin. Transl. Oncol. 19(2), 211–218 (2017).10.1007/s12094-016-1526-927364695ObeidJ.-P.et al., “Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat,” Clin. Transl. Oncol. 19(2), 211–218 (2017).10.1007/s12094-016-1526-927364695, ObeidJ.-P.et al., “Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat,” Clin. Transl. Oncol. 19(2), 211–218 (2017).10.1007/s12094-016-1526-927364695
-
(GevaertO.et al., “Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data: methods and preliminary results,” Radiology 264(2), 387–396 (2012).RADLAX0033-841910.1148/radiol.1211160722723499)
GevaertO.et al., “Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data: methods and preliminary results,” Radiology 264(2), 387–396 (2012).RADLAX0033-841910.1148/radiol.1211160722723499GevaertO.et al., “Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data: methods and preliminary results,” Radiology 264(2), 387–396 (2012).RADLAX0033-841910.1148/radiol.1211160722723499, GevaertO.et al., “Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data: methods and preliminary results,” Radiology 264(2), 387–396 (2012).RADLAX0033-841910.1148/radiol.1211160722723499
-
(YamamotoS.et al., “ALK molecular phenotype in non–small cell lung cancer: CT radiogenomic characterization,” Radiology 272(2), 568–576 (2014).RADLAX0033-841910.1148/radiol.1414078924885982)
YamamotoS.et al., “ALK molecular phenotype in non–small cell lung cancer: CT radiogenomic characterization,” Radiology 272(2), 568–576 (2014).RADLAX0033-841910.1148/radiol.1414078924885982YamamotoS.et al., “ALK molecular phenotype in non–small cell lung cancer: CT radiogenomic characterization,” Radiology 272(2), 568–576 (2014).RADLAX0033-841910.1148/radiol.1414078924885982, YamamotoS.et al., “ALK molecular phenotype in non–small cell lung cancer: CT radiogenomic characterization,” Radiology 272(2), 568–576 (2014).RADLAX0033-841910.1148/radiol.1414078924885982
-
Zilong Hu, Jinshan Tang, Ziming Wang, Kai Zhang, Ling Zhang, Qingling Sun (2018)
Deep learning for image-based cancer detection and diagnosis - A surveyPattern Recognit., 83
-
(LoP.et al., “Variability in CT lung-nodule quantification: effects of dose reduction and reconstruction methods on density and texture based features,” Med. Phys. 43(8Part1), 4854–4865 (2016).10.1118/1.495484527487903)
LoP.et al., “Variability in CT lung-nodule quantification: effects of dose reduction and reconstruction methods on density and texture based features,” Med. Phys. 43(8Part1), 4854–4865 (2016).10.1118/1.495484527487903LoP.et al., “Variability in CT lung-nodule quantification: effects of dose reduction and reconstruction methods on density and texture based features,” Med. Phys. 43(8Part1), 4854–4865 (2016).10.1118/1.495484527487903, LoP.et al., “Variability in CT lung-nodule quantification: effects of dose reduction and reconstruction methods on density and texture based features,” Med. Phys. 43(8Part1), 4854–4865 (2016).10.1118/1.495484527487903
-
Jian Wang, Hengde Zhu, Shuihua Wang, Yudong Zhang (2020)
A Review of Deep Learning on Medical Image AnalysisMobile Networks and Applications, 26
-
Muhammad Shafiq-ul-Hassan, Geoffrey Zhang, D. Hunt, K. Latifi, G. Ullah, R. Gillies, E. Moros (2017)
Accounting for reconstruction kernel-induced variability in CT radiomic features using noise power spectraJournal of Medical Imaging, 5
-
(KuoM. D.JamshidiN., “Behind the numbers: decoding molecular phenotypes with radiogenomics—guiding principles and technical considerations,” Radiology 270(2), 320–325 (2014).RADLAX0033-841910.1148/radiol.1313219524471381)
KuoM. D.JamshidiN., “Behind the numbers: decoding molecular phenotypes with radiogenomics—guiding principles and technical considerations,” Radiology 270(2), 320–325 (2014).RADLAX0033-841910.1148/radiol.1313219524471381KuoM. D.JamshidiN., “Behind the numbers: decoding molecular phenotypes with radiogenomics—guiding principles and technical considerations,” Radiology 270(2), 320–325 (2014).RADLAX0033-841910.1148/radiol.1313219524471381, KuoM. D.JamshidiN., “Behind the numbers: decoding molecular phenotypes with radiogenomics—guiding principles and technical considerations,” Radiology 270(2), 320–325 (2014).RADLAX0033-841910.1148/radiol.1313219524471381
-
Jose Tamez-Peña, J. Rodríguez-Rojas, Hugo Gómez-Rueda, J. Celaya-Padilla, Roxana-Alicia Rivera-Prieto, R. Palacios-Corona, Margarita Garza-Montemayor, S. Cardona-Huerta, V. Treviño (2018)
Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancerPLoS ONE, 13
-
(LuC.-F.et al., “Machine learning-based radiomics for molecular subtyping of gliomas,” Clin. Cancer Res. 24(18), 4429–4436 (2018).CCREF41078-043210.1158/1078-0432.CCR-17-344529789422)
LuC.-F.et al., “Machine learning-based radiomics for molecular subtyping of gliomas,” Clin. Cancer Res. 24(18), 4429–4436 (2018).CCREF41078-043210.1158/1078-0432.CCR-17-344529789422LuC.-F.et al., “Machine learning-based radiomics for molecular subtyping of gliomas,” Clin. Cancer Res. 24(18), 4429–4436 (2018).CCREF41078-043210.1158/1078-0432.CCR-17-344529789422, LuC.-F.et al., “Machine learning-based radiomics for molecular subtyping of gliomas,” Clin. Cancer Res. 24(18), 4429–4436 (2018).CCREF41078-043210.1158/1078-0432.CCR-17-344529789422
-
(TaberK. A. J.DickinsonB. D.WilsonM., “The promise and challenges of next-generation genome sequencing for clinical care,” JAMA Internal Med. 174(2), 275–280 (2014).10.1001/jamainternmed.2013.1204824217348)
TaberK. A. J.DickinsonB. D.WilsonM., “The promise and challenges of next-generation genome sequencing for clinical care,” JAMA Internal Med. 174(2), 275–280 (2014).10.1001/jamainternmed.2013.1204824217348TaberK. A. J.DickinsonB. D.WilsonM., “The promise and challenges of next-generation genome sequencing for clinical care,” JAMA Internal Med. 174(2), 275–280 (2014).10.1001/jamainternmed.2013.1204824217348, TaberK. A. J.DickinsonB. D.WilsonM., “The promise and challenges of next-generation genome sequencing for clinical care,” JAMA Internal Med. 174(2), 275–280 (2014).10.1001/jamainternmed.2013.1204824217348
-
(SahaA.et al., “A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features,” Br. J. Cancer 119(4), 508–516 (2018).10.1038/s41416-018-0185-830033447)
SahaA.et al., “A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features,” Br. J. Cancer 119(4), 508–516 (2018).10.1038/s41416-018-0185-830033447SahaA.et al., “A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features,” Br. J. Cancer 119(4), 508–516 (2018).10.1038/s41416-018-0185-830033447, SahaA.et al., “A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features,” Br. J. Cancer 119(4), 508–516 (2018).10.1038/s41416-018-0185-830033447
-
Albert Yeh, Hui Li, Yitan Zhu, Jing Zhang, G. Khramtsova, K. Drukker, A. Edwards, S. McGregor, T. Yoshimatsu, Yonglan Zheng, Q. Niu, H. Abe, Jeffrey Mueller, S. Conzen, Yuan Ji, M. Giger, O. Olopade (2019)
Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profilingCancer Imaging, 19
-
M. Nishino, S. Dahlberg, L. Fulton, S. Digumarthy, H. Hatabu, B. Johnson, L. Sequist (2016)
Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib.Academic radiology, 23 3
-
(JaffeC. C., “Imaging and genomics: is there a synergy?” Radiology 264(2), 329–331 (2012).RADLAX0033-841910.1148/radiol.1212087122821693)
JaffeC. C., “Imaging and genomics: is there a synergy?” Radiology 264(2), 329–331 (2012).RADLAX0033-841910.1148/radiol.1212087122821693JaffeC. C., “Imaging and genomics: is there a synergy?” Radiology 264(2), 329–331 (2012).RADLAX0033-841910.1148/radiol.1212087122821693, JaffeC. C., “Imaging and genomics: is there a synergy?” Radiology 264(2), 329–331 (2012).RADLAX0033-841910.1148/radiol.1212087122821693
-
E. Velazquez, C. Parmar, Y. Liu, T. Coroller, G. Cruz, O. Stringfield, Z. Ye, M. Makrigiorgos, F. Fennessy, R. Mak, R. Gillies, John Quackenbush, H. Aerts (2017)
Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer.Cancer research, 77 14
-
H. Yoon, I. Sohn, J. Cho, Ho Lee, Jae-Hun Kim, Yoon-La Choi, Hyeseung Kim, Genehee Lee, K. Lee, Jhingook Kim (2015)
Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics ApproachMedicine, 94
-
(SharmaN.AggarwalL. M., “Automated medical image segmentation techniques,” J. Med. Phys. 35(1), 3 (2010).10.4103/0971-6203.5877720177565)
SharmaN.AggarwalL. M., “Automated medical image segmentation techniques,” J. Med. Phys. 35(1), 3 (2010).10.4103/0971-6203.5877720177565SharmaN.AggarwalL. M., “Automated medical image segmentation techniques,” J. Med. Phys. 35(1), 3 (2010).10.4103/0971-6203.5877720177565, SharmaN.AggarwalL. M., “Automated medical image segmentation techniques,” J. Med. Phys. 35(1), 3 (2010).10.4103/0971-6203.5877720177565
-
L. Clarke, R. Nordstrom, Huiming Zhang, Pushpa Tandon, Yantian Zhang, George Redmond, K. Farahani, G. Kelloff, Lori Henderson, L. Shankar, J. Deye, J. Capala, P. Jacobs (2014)
The Quantitative Imaging Network: NCI's Historical Perspective and Planned Goals.Translational oncology, 7 1
-
(YoonH. J.et al., “Decoding tumor phenotypes for ALK, ROS1, and RET fusions in lung adenocarcinoma using a radiomics approach,” Medicine 94(41), e1753 (2015).10.1097/MD.000000000000175326469915)
YoonH. J.et al., “Decoding tumor phenotypes for ALK, ROS1, and RET fusions in lung adenocarcinoma using a radiomics approach,” Medicine 94(41), e1753 (2015).10.1097/MD.000000000000175326469915YoonH. J.et al., “Decoding tumor phenotypes for ALK, ROS1, and RET fusions in lung adenocarcinoma using a radiomics approach,” Medicine 94(41), e1753 (2015).10.1097/MD.000000000000175326469915, YoonH. J.et al., “Decoding tumor phenotypes for ALK, ROS1, and RET fusions in lung adenocarcinoma using a radiomics approach,” Medicine 94(41), e1753 (2015).10.1097/MD.000000000000175326469915
-
(2018)
a study of 922 subjects and 529 DCE-MRI features,” Br -
Z. Bodalal, S. Trebeschi, T. Nguyen-Kim, W. Schats, R. Beets-Tan (2019)
Radiogenomics: bridging imaging and genomicsAbdominal Radiology, 44
-
(GilliesR. J.KinahanP. E.HricakH., “Radiomics: images are more than pictures, they are data,” Radiology 278(2), 563–577 (2016).RADLAX0033-841910.1148/radiol.201515116926579733)
GilliesR. J.KinahanP. E.HricakH., “Radiomics: images are more than pictures, they are data,” Radiology 278(2), 563–577 (2016).RADLAX0033-841910.1148/radiol.201515116926579733GilliesR. J.KinahanP. E.HricakH., “Radiomics: images are more than pictures, they are data,” Radiology 278(2), 563–577 (2016).RADLAX0033-841910.1148/radiol.201515116926579733, GilliesR. J.KinahanP. E.HricakH., “Radiomics: images are more than pictures, they are data,” Radiology 278(2), 563–577 (2016).RADLAX0033-841910.1148/radiol.201515116926579733
-
(HuZ.et al., “Deep learning for image-based cancer detection and diagnosis: a survey,” Pattern Recognit. 83, 134–149 (2018).10.1016/j.patcog.2018.05.014)
HuZ.et al., “Deep learning for image-based cancer detection and diagnosis: a survey,” Pattern Recognit. 83, 134–149 (2018).10.1016/j.patcog.2018.05.014HuZ.et al., “Deep learning for image-based cancer detection and diagnosis: a survey,” Pattern Recognit. 83, 134–149 (2018).10.1016/j.patcog.2018.05.014, HuZ.et al., “Deep learning for image-based cancer detection and diagnosis: a survey,” Pattern Recognit. 83, 134–149 (2018).10.1016/j.patcog.2018.05.014
-
(BakasS.et al., “In vivo detection of EGFRvIII in glioblastoma via perfusion magnetic resonance imaging signature consistent with deep peritumoral infiltration: the φ-index,” Clin. Cancer Res. 23(16), 4724–4734 (2017).CCREF41078-043210.1158/1078-0432.CCR-16-187128428190)
BakasS.et al., “In vivo detection of EGFRvIII in glioblastoma via perfusion magnetic resonance imaging signature consistent with deep peritumoral infiltration: the φ-index,” Clin. Cancer Res. 23(16), 4724–4734 (2017).CCREF41078-043210.1158/1078-0432.CCR-16-187128428190BakasS.et al., “In vivo detection of EGFRvIII in glioblastoma via perfusion magnetic resonance imaging signature consistent with deep peritumoral infiltration: the φ-index,” Clin. Cancer Res. 23(16), 4724–4734 (2017).CCREF41078-043210.1158/1078-0432.CCR-16-187128428190, BakasS.et al., “In vivo detection of EGFRvIII in glioblastoma via perfusion magnetic resonance imaging signature consistent with deep peritumoral infiltration: the φ-index,” Clin. Cancer Res. 23(16), 4724–4734 (2017).CCREF41078-043210.1158/1078-0432.CCR-16-187128428190
-
(TuW.et al., “Radiomics signature: a potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology,” Lung Cancer 132, 28–35 (2019).10.1016/j.lungcan.2019.03.02531097090)
TuW.et al., “Radiomics signature: a potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology,” Lung Cancer 132, 28–35 (2019).10.1016/j.lungcan.2019.03.02531097090TuW.et al., “Radiomics signature: a potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology,” Lung Cancer 132, 28–35 (2019).10.1016/j.lungcan.2019.03.02531097090, TuW.et al., “Radiomics signature: a potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology,” Lung Cancer 132, 28–35 (2019).10.1016/j.lungcan.2019.03.02531097090
-
Chia-Feng Lu, Fei-Ting Hsu, K. Hsieh, Y. Kao, Sho-Jen Cheng, J. Hsu, P. Tsai, Ray-Jade Chen, Chao-Ching Huang, Y. Yen, Cheng-Yu Chen (2018)
Machine Learning–Based Radiomics for Molecular Subtyping of GliomasClinical Cancer Research, 24
-
(GrimmL. J.ZhangJ.MazurowskiM. A., “Computational approach to radiogenomics of breast cancer: luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms,” J. Magn. Reson. Imaging 42(4), 902–907 (2015).10.1002/jmri.2487925777181)
GrimmL. J.ZhangJ.MazurowskiM. A., “Computational approach to radiogenomics of breast cancer: luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms,” J. Magn. Reson. Imaging 42(4), 902–907 (2015).10.1002/jmri.2487925777181GrimmL. J.ZhangJ.MazurowskiM. A., “Computational approach to radiogenomics of breast cancer: luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms,” J. Magn. Reson. Imaging 42(4), 902–907 (2015).10.1002/jmri.2487925777181, GrimmL. J.ZhangJ.MazurowskiM. A., “Computational approach to radiogenomics of breast cancer: luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms,” J. Magn. Reson. Imaging 42(4), 902–907 (2015).10.1002/jmri.2487925777181
-
A. Buckler, L. Bresolin, N. Dunnick, D. Sullivan (2011)
A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging.Radiology, 258 3
-
(2020)
an initial result,” Acad -
(ZhangX.et al., “Radiomics strategy for molecular subtype stratification of lower-grade glioma: detecting IDH and TP53 mutations based on multimodal MRI,” J. Magn. Reson. Imaging 48(4), 916–926 (2018).10.1002/jmri.2596029394005)
ZhangX.et al., “Radiomics strategy for molecular subtype stratification of lower-grade glioma: detecting IDH and TP53 mutations based on multimodal MRI,” J. Magn. Reson. Imaging 48(4), 916–926 (2018).10.1002/jmri.2596029394005ZhangX.et al., “Radiomics strategy for molecular subtype stratification of lower-grade glioma: detecting IDH and TP53 mutations based on multimodal MRI,” J. Magn. Reson. Imaging 48(4), 916–926 (2018).10.1002/jmri.2596029394005, ZhangX.et al., “Radiomics strategy for molecular subtype stratification of lower-grade glioma: detecting IDH and TP53 mutations based on multimodal MRI,” J. Magn. Reson. Imaging 48(4), 916–926 (2018).10.1002/jmri.2596029394005
-
(LiH.et al., “MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays,” Radiology 281(2), 382–391 (2016).RADLAX0033-841910.1148/radiol.201615211027144536)
LiH.et al., “MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays,” Radiology 281(2), 382–391 (2016).RADLAX0033-841910.1148/radiol.201615211027144536LiH.et al., “MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays,” Radiology 281(2), 382–391 (2016).RADLAX0033-841910.1148/radiol.201615211027144536, LiH.et al., “MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays,” Radiology 281(2), 382–391 (2016).RADLAX0033-841910.1148/radiol.201615211027144536
-
Shota Yamamoto, R. Korn, R. Oklu, C. Migdal, M. Gotway, G. Weiss, G. Weiss, A. Iafrate, Dong-Wan Kim, M. Kuo (2014)
ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.Radiology, 272 2
-
A. Zwanenburg, M. Vallières, M. Abdalah, H. Aerts, V. Andrearczyk, A. Apte, S. Ashrafinia, S. Bakas, R. Beukinga, R. Boellaard, M. Bogowicz, L. Boldrini, I. Buvat, G. Cook, C. Davatzikos, A. Depeursinge, M. Desseroit, N. Dinapoli, C. Dinh, Sebastian Echegaray, I. Naqa, Andrey Fedorov, R. Gatta, R. Gillies, V. Goh, M. Götz, M. Guckenberger, S. Ha, M. Hatt, Fabian Isensee, P. Lambin, S. Leger, R. Leijenaar, J. Lenkowicz, F. Lippert, Are Losnegård, Klaus Maier-Hein, O. Morin, H. Müller, S. Napel, C. Nioche, Fanny Orlhac, Sarthak Pati, E. Pfaehler, A. Rahmim, Arvind Rao, Jonas Scherer, M. Siddique, N. Sijtsema, Jairo Fernandez, E. Spezi, R. Steenbakkers, S. Tanadini-Lang, D. Thorwarth, E. Troost, T. Upadhaya, V. Valentini, L. Dijk, Joost Griethuysen, F. Velden, P. Whybra, C. Richter, S. Löck (2016)
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.Radiology
-
J. McCarthy, H. McLeod, G. Ginsburg (2013)
Genomic Medicine: A Decade of Successes, Challenges, and OpportunitiesScience Translational Medicine, 5
-
(McCarthyJ. J.McLeodH. L.GinsburgG. S., “Genomic medicine: a decade of successes, challenges, and opportunities,” Sci. Transl. Med. 5(189), 189sr4 (2013).10.1126/scitranslmed.300578523761042)
McCarthyJ. J.McLeodH. L.GinsburgG. S., “Genomic medicine: a decade of successes, challenges, and opportunities,” Sci. Transl. Med. 5(189), 189sr4 (2013).10.1126/scitranslmed.300578523761042McCarthyJ. J.McLeodH. L.GinsburgG. S., “Genomic medicine: a decade of successes, challenges, and opportunities,” Sci. Transl. Med. 5(189), 189sr4 (2013).10.1126/scitranslmed.300578523761042, McCarthyJ. J.McLeodH. L.GinsburgG. S., “Genomic medicine: a decade of successes, challenges, and opportunities,” Sci. Transl. Med. 5(189), 189sr4 (2013).10.1126/scitranslmed.300578523761042
-
R. Gillies, Paul Kinahan, H. Hricak (2015)
Radiomics: Images Are More than Pictures, They Are DataRadiology, 278
-
(LambinP.et al., “Radiomics: the bridge between medical imaging and personalized medicine,” Nat. Rev. Clin. Oncol. 14(12), 749–762 (2017).10.1038/nrclinonc.2017.14128975929)
LambinP.et al., “Radiomics: the bridge between medical imaging and personalized medicine,” Nat. Rev. Clin. Oncol. 14(12), 749–762 (2017).10.1038/nrclinonc.2017.14128975929LambinP.et al., “Radiomics: the bridge between medical imaging and personalized medicine,” Nat. Rev. Clin. Oncol. 14(12), 749–762 (2017).10.1038/nrclinonc.2017.14128975929, LambinP.et al., “Radiomics: the bridge between medical imaging and personalized medicine,” Nat. Rev. Clin. Oncol. 14(12), 749–762 (2017).10.1038/nrclinonc.2017.14128975929
-
(ZwanenburgA.et al., “The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping,” Radiology 295(2), 328–338 (2020).RADLAX0033-841910.1148/radiol.202019114532154773)
ZwanenburgA.et al., “The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping,” Radiology 295(2), 328–338 (2020).RADLAX0033-841910.1148/radiol.202019114532154773ZwanenburgA.et al., “The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping,” Radiology 295(2), 328–338 (2020).RADLAX0033-841910.1148/radiol.202019114532154773, ZwanenburgA.et al., “The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping,” Radiology 295(2), 328–338 (2020).RADLAX0033-841910.1148/radiol.202019114532154773
-
(DingL.et al., “Analysis of next-generation genomic data in cancer: accomplishments and challenges,” Hum. Mol. Genet. 19(R2), R188–R196 (2010).10.1093/hmg/ddq39120843826)
DingL.et al., “Analysis of next-generation genomic data in cancer: accomplishments and challenges,” Hum. Mol. Genet. 19(R2), R188–R196 (2010).10.1093/hmg/ddq39120843826DingL.et al., “Analysis of next-generation genomic data in cancer: accomplishments and challenges,” Hum. Mol. Genet. 19(R2), R188–R196 (2010).10.1093/hmg/ddq39120843826, DingL.et al., “Analysis of next-generation genomic data in cancer: accomplishments and challenges,” Hum. Mol. Genet. 19(R2), R188–R196 (2010).10.1093/hmg/ddq39120843826
-
Neeraj Sharma, L. Aggarwal (2010)
Automated medical image segmentation techniquesJournal of Medical Physics / Association of Medical Physicists of India, 35
-
P. Lambin, Emmanuel Rios-Velazquez, R. Leijenaar, S. Carvalho, R. Stiphout, P. Granton, C. Zegers, R. Gillies, R. Boellard, A. Dekker, H. Aerts (2012)
Radiomics: extracting more information from medical images using advanced feature analysis.European journal of cancer, 48 4
-
P. Zinn, S. Singh, Aikaterini Kotrotsou, Srishti Abrol, Ginu Thomas, Jennifer Mosley, A. Elakkad, Islam Hassan, Ashok Kumar, R. Colen (2017)
Distinct Radiomic Phenotypes Define Glioblastoma TP53-PTEN-EGFR Mutational Landscape.Neurosurgery, 64 CN_suppl_1
-
(ZhaoB.et al., “Reproducibility of radiomics for deciphering tumor phenotype with imaging,” Sci. Rep. 6(1), 23428 (2016).10.1038/srep2342827009765)
ZhaoB.et al., “Reproducibility of radiomics for deciphering tumor phenotype with imaging,” Sci. Rep. 6(1), 23428 (2016).10.1038/srep2342827009765ZhaoB.et al., “Reproducibility of radiomics for deciphering tumor phenotype with imaging,” Sci. Rep. 6(1), 23428 (2016).10.1038/srep2342827009765, ZhaoB.et al., “Reproducibility of radiomics for deciphering tumor phenotype with imaging,” Sci. Rep. 6(1), 23428 (2016).10.1038/srep2342827009765
-
(2010)
accomplishments and challenges,” Hum -
S. Yip, H. Aerts (2016)
Applications and limitations of radiomicsPhysics in Medicine & Biology, 61
-
S. Bakas, H. Akbari, J. Pisapia, M. Martinez-Lage, Martin Rozycki, Saima Rathore, N. Dahmane, D. O’Rourke, C. Davatzikos (2017)
In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The ϕ-IndexClinical Cancer Research, 23
-
Ahmad Algohary, R. Shiradkar, Shivani Pahwa, A. Purysko, S. Verma, D. Moses, R. Shnier, A. Haynes, W. Delprado, J. Thompson, S. Tirumani, A. Mahran, A. Rastinehad, L. Ponsky, P. Stricker, A. Madabhushi (2020)
Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site StudyCancers, 12
-
(YipS. S. F.AertsH. J. W. L., “Applications and limitations of radiomics,” Phys. Med. Biol. 61(13), R150 (2016).PHMBA70031-915510.1088/0031-9155/61/13/R15027269645)
YipS. S. F.AertsH. J. W. L., “Applications and limitations of radiomics,” Phys. Med. Biol. 61(13), R150 (2016).PHMBA70031-915510.1088/0031-9155/61/13/R15027269645YipS. S. F.AertsH. J. W. L., “Applications and limitations of radiomics,” Phys. Med. Biol. 61(13), R150 (2016).PHMBA70031-915510.1088/0031-9155/61/13/R15027269645, YipS. S. F.AertsH. J. W. L., “Applications and limitations of radiomics,” Phys. Med. Biol. 61(13), R150 (2016).PHMBA70031-915510.1088/0031-9155/61/13/R15027269645
-
A. Marusyk, K. Polyak (2010)
Tumor heterogeneity: causes and consequences.Biochimica et biophysica acta, 1805 1
-
(2017)
the φ-index,” Clin -
(2014)
NCI’s historical perspective and planned goals,” Transl -
Katherine Taber, Barry Dickinson, Modena Wilson (2014)
The promise and challenges of next-generation genome sequencing for clinical care.JAMA internal medicine, 174 2
-
Mengmeng Jiang, Dazhen Sun, Yinglong Guo, Yixian Guo, Jie Xiao, Lisheng Wang, X. Yao (2020)
Assessing PD-L1 Expression Level by Radiomic Features From PET/CT in Nonsmall Cell Lung Cancer Patients: An Initial Result.Academic radiology
-
Paul Yushkevich, Yang Gao, G. Gerig (2016)
ITK-SNAP: An interactive tool for semi-automatic segmentation of multi-modality biomedical images2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
-
(Shukla-DaveA.et al., “Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials,” J. Magn. Reson. Imaging 49(7), e101–e121 (2019).10.1002/jmri.2651830451345)
Shukla-DaveA.et al., “Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials,” J. Magn. Reson. Imaging 49(7), e101–e121 (2019).10.1002/jmri.2651830451345Shukla-DaveA.et al., “Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials,” J. Magn. Reson. Imaging 49(7), e101–e121 (2019).10.1002/jmri.2651830451345, Shukla-DaveA.et al., “Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials,” J. Magn. Reson. Imaging 49(7), e101–e121 (2019).10.1002/jmri.2651830451345
-
Xi Zhang, Qiang Tian, Liang Wang, Yang Liu, Baojuan Li, Zhengrong Liang, Peng Gao, Kaizhong Zheng, Bofeng Zhao, Hongbing Lu (2018)
Radiomics Strategy for Molecular Subtype Stratification of Lower‐Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRIJournal of Magnetic Resonance Imaging, 48
-
(MackinD.et al., “Effect of tube current on computed tomography radiomic features,” Sci. Rep. 8(1), 2354 (2018).10.1038/s41598-018-20713-629403060)
MackinD.et al., “Effect of tube current on computed tomography radiomic features,” Sci. Rep. 8(1), 2354 (2018).10.1038/s41598-018-20713-629403060MackinD.et al., “Effect of tube current on computed tomography radiomic features,” Sci. Rep. 8(1), 2354 (2018).10.1038/s41598-018-20713-629403060, MackinD.et al., “Effect of tube current on computed tomography radiomic features,” Sci. Rep. 8(1), 2354 (2018).10.1038/s41598-018-20713-629403060
-
(MarusykA.PolyakK., “Tumor heterogeneity: causes and consequences,” Biochim. Biophys. Acta 1805(1), 105–117 (2010).10.1016/j.bbcan.2009.11.00219931353)
MarusykA.PolyakK., “Tumor heterogeneity: causes and consequences,” Biochim. Biophys. Acta 1805(1), 105–117 (2010).10.1016/j.bbcan.2009.11.00219931353MarusykA.PolyakK., “Tumor heterogeneity: causes and consequences,” Biochim. Biophys. Acta 1805(1), 105–117 (2010).10.1016/j.bbcan.2009.11.00219931353, MarusykA.PolyakK., “Tumor heterogeneity: causes and consequences,” Biochim. Biophys. Acta 1805(1), 105–117 (2010).10.1016/j.bbcan.2009.11.00219931353
-
P. Grossmann, O. Stringfield, N. El-Hachem, M. Bui, E. Velazquez, C. Parmar, R. Leijenaar, B. Haibe-Kains, P. Lambin, R. Gillies, H. Aerts (2017)
Defining the biological basis of radiomic phenotypes in lung cancereLife, 6
-
(GrossmannP.et al., “Defining the biological basis of radiomic phenotypes in lung cancer,” eLife 6, e23421 (2017).10.7554/eLife.2342128731408)
GrossmannP.et al., “Defining the biological basis of radiomic phenotypes in lung cancer,” eLife 6, e23421 (2017).10.7554/eLife.2342128731408GrossmannP.et al., “Defining the biological basis of radiomic phenotypes in lung cancer,” eLife 6, e23421 (2017).10.7554/eLife.2342128731408, GrossmannP.et al., “Defining the biological basis of radiomic phenotypes in lung cancer,” eLife 6, e23421 (2017).10.7554/eLife.2342128731408
-
P. Zinn, S. Singh, Aikaterini Kotrotsou, Islam Hassan, Ginu Thomas, M. Luedi, A. Elakkad, N. Elshafeey, Tagwa Idris, Jennifer Mosley, J. Gumin, G. Fuller, J. Groot, V. Baladandayuthapani, E. Sulman, Ashok Kumar, R. Sawaya, F. Lang, D. Piwnica-Worms, R. Colen (2018)
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft ModelsClinical Cancer Research, 24
-
M. Meyer, J. Ronald, F. Vernuccio, R. Nelson, J. Ramirez-Giraldo, J. Solomon, B. Patel, E. Samei, D. Marin (2019)
Reproducibility of CT Radiomic Features within the Same Patient: Influence of Radiation Dose and CT Reconstruction Settings.Radiology
-
A. Chaddad, P. Zinn, R. Colen (2015)
Radiomics texture feature extraction for characterizing GBM phenotypes using GLCM2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI)
-
(VaidyanathanR.et al., “Cancer diagnosis: from tumor to liquid biopsy and beyond,” Lab Chip 19(1), 11–34 (2019).10.1039/c8lc00684a)
VaidyanathanR.et al., “Cancer diagnosis: from tumor to liquid biopsy and beyond,” Lab Chip 19(1), 11–34 (2019).10.1039/c8lc00684aVaidyanathanR.et al., “Cancer diagnosis: from tumor to liquid biopsy and beyond,” Lab Chip 19(1), 11–34 (2019).10.1039/c8lc00684a, VaidyanathanR.et al., “Cancer diagnosis: from tumor to liquid biopsy and beyond,” Lab Chip 19(1), 11–34 (2019).10.1039/c8lc00684a
-
(WuJ.et al., “Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: model discovery and external validation,” J. Magn. Reson. Imaging 46(4), 1017–1027 (2017).10.1002/jmri.2566128177554)
WuJ.et al., “Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: model discovery and external validation,” J. Magn. Reson. Imaging 46(4), 1017–1027 (2017).10.1002/jmri.2566128177554WuJ.et al., “Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: model discovery and external validation,” J. Magn. Reson. Imaging 46(4), 1017–1027 (2017).10.1002/jmri.2566128177554, WuJ.et al., “Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: model discovery and external validation,” J. Magn. Reson. Imaging 46(4), 1017–1027 (2017).10.1002/jmri.2566128177554
-
P. Lo, S. Young, H. Kim, Matthew Brown, M. McNitt-Gray (2016)
Variability in CT lung-nodule quantification: Effects of dose reduction and reconstruction methods on density and texture based featuresMedical Physics, 43
-
J-J Wang, Ke-feng Lei, F. Han (2018)
Tumor microenvironment: recent advances in various cancer treatments.European review for medical and pharmacological sciences, 22 12
-
(2015)
luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms,” J -
(2018)
a preliminary study,” Sci -
C. Jaffe (2012)
Imaging and genomics: is there a synergy?Radiology, 264 2
-
Hui Li, Yitan Zhu, E. Burnside, K. Drukker, K. Hoadley, C. Fan, S. Conzen, G. Whitman, E. Sutton, J. Net, M. Ganott, Erich Huang, E. Morris, C. Perou, Yuan Ji, M. Giger (2016)
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.Radiology, 281 2
-
R. Ger, J. Meier, R. Pahlka, Skylar Gay, R. Mumme, C. Fuller, Heng Li, R. Howell, R. Layman, R. Stafford, Shouhao Zhou, O. Mawlawi, L. Court (2019)
Effects of alterations in positron emission tomography imaging parameters on radiomics featuresPLoS ONE, 14
-
(ChaddadA.ZinnP. O.ColenR. R., “Radiomics texture feature extraction for characterizing GBM phenotypes using GLCM,” in IEEE 12th Int. Symp. Biomed. Imaging, IEEE (2015).10.1109/ISBI.2015.7163822)
ChaddadA.ZinnP. O.ColenR. R., “Radiomics texture feature extraction for characterizing GBM phenotypes using GLCM,” in IEEE 12th Int. Symp. Biomed. Imaging, IEEE (2015).10.1109/ISBI.2015.7163822ChaddadA.ZinnP. O.ColenR. R., “Radiomics texture feature extraction for characterizing GBM phenotypes using GLCM,” in IEEE 12th Int. Symp. Biomed. Imaging, IEEE (2015).10.1109/ISBI.2015.7163822, ChaddadA.ZinnP. O.ColenR. R., “Radiomics texture feature extraction for characterizing GBM phenotypes using GLCM,” in IEEE 12th Int. Symp. Biomed. Imaging, IEEE (2015).10.1109/ISBI.2015.7163822
-
Seunggyun Ha, Sohyun Park, Ji-In Bang, Eun-Kyu Kim, Ho-Yyoung Lee (2017)
Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and PrognosisScientific Reports, 7
-
Ashirbani Saha, Michael Harowicz, Lars Grimm, Connie Kim, S. Ghate, R. Walsh, M. Mazurowski (2018)
A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI featuresBritish Journal of Cancer, 119
-
(ZinnP. O.et al., “A coclinical radiogenomic validation study: conserved magnetic resonance radiomic appearance of periostin-expressing glioblastoma in patients and xenograft models,” Clin. Cancer Res. 24(24), 6288–6299 (2018).CCREF41078-043210.1158/1078-0432.CCR-17-342030054278)
ZinnP. O.et al., “A coclinical radiogenomic validation study: conserved magnetic resonance radiomic appearance of periostin-expressing glioblastoma in patients and xenograft models,” Clin. Cancer Res. 24(24), 6288–6299 (2018).CCREF41078-043210.1158/1078-0432.CCR-17-342030054278ZinnP. O.et al., “A coclinical radiogenomic validation study: conserved magnetic resonance radiomic appearance of periostin-expressing glioblastoma in patients and xenograft models,” Clin. Cancer Res. 24(24), 6288–6299 (2018).CCREF41078-043210.1158/1078-0432.CCR-17-342030054278, ZinnP. O.et al., “A coclinical radiogenomic validation study: conserved magnetic resonance radiomic appearance of periostin-expressing glioblastoma in patients and xenograft models,” Clin. Cancer Res. 24(24), 6288–6299 (2018).CCREF41078-043210.1158/1078-0432.CCR-17-342030054278
-
(Tamez-PenaJ.-G.et al., “Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer,” PLoS One 13(3), e0193871 (2018).10.1371/journal.pone.019387129596496)
Tamez-PenaJ.-G.et al., “Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer,” PLoS One 13(3), e0193871 (2018).10.1371/journal.pone.019387129596496Tamez-PenaJ.-G.et al., “Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer,” PLoS One 13(3), e0193871 (2018).10.1371/journal.pone.019387129596496, Tamez-PenaJ.-G.et al., “Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer,” PLoS One 13(3), e0193871 (2018).10.1371/journal.pone.019387129596496
-
(ZhouM.et al., “Non–small cell lung cancer radiogenomics map identifies relationships between molecular and imaging phenotypes with prognostic implications,” Radiology 286(1), 307–315 (2018).RADLAX0033-841910.1148/radiol.201716184528727543)
ZhouM.et al., “Non–small cell lung cancer radiogenomics map identifies relationships between molecular and imaging phenotypes with prognostic implications,” Radiology 286(1), 307–315 (2018).RADLAX0033-841910.1148/radiol.201716184528727543ZhouM.et al., “Non–small cell lung cancer radiogenomics map identifies relationships between molecular and imaging phenotypes with prognostic implications,” Radiology 286(1), 307–315 (2018).RADLAX0033-841910.1148/radiol.201716184528727543, ZhouM.et al., “Non–small cell lung cancer radiogenomics map identifies relationships between molecular and imaging phenotypes with prognostic implications,” Radiology 286(1), 307–315 (2018).RADLAX0033-841910.1148/radiol.201716184528727543
-
M. Mazurowski (2015)
Radiogenomics: what it is and why it is important.Journal of the American College of Radiology : JACR, 12 8
-
P. Lambin, R. Leijenaar, T. Deist, J. Peerlings, E. Jong, J. Timmeren, S. Sanduleanu, R. Larue, A. Even, A. Jochems, Y. Wijk, H. Woodruff, J. Soest, T. Lustberg, E. Roelofs, W. Elmpt, A. Dekker, F. Mottaghy, J. Wildberger, S. Walsh (2017)
Radiomics: the bridge between medical imaging and personalized medicineNature Reviews Clinical Oncology, 14
-
(HsuJ.-S.et al., “Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma,” J. Thorac. Imaging 29(6), 357–363 (2014).10.1097/RTI.000000000000011625303964)
HsuJ.-S.et al., “Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma,” J. Thorac. Imaging 29(6), 357–363 (2014).10.1097/RTI.000000000000011625303964HsuJ.-S.et al., “Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma,” J. Thorac. Imaging 29(6), 357–363 (2014).10.1097/RTI.000000000000011625303964, HsuJ.-S.et al., “Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma,” J. Thorac. Imaging 29(6), 357–363 (2014).10.1097/RTI.000000000000011625303964
-
A. Shukla-Dave, N. Obuchowski, T. Chenevert, S. Jambawalikar, L. Schwartz, D. Malyarenko, Wei Huang, S. Noworolski, R. Young, M. Shiroishi, Harrison Kim, C. Coolens, H. Laue, C. Chung, M. Rosen, M. Boss, E. Jackson (2018)
Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE‐MRI derived biomarkers in multicenter oncology trialsJournal of Magnetic Resonance Imaging, 49
-
(WangJ.et al., “A review of deep learning on medical image analysis,” Mobile Networks Appl. 25(1), 351–380 (2020).10.1007/s11036-020-01672-7)
WangJ.et al., “A review of deep learning on medical image analysis,” Mobile Networks Appl. 25(1), 351–380 (2020).10.1007/s11036-020-01672-7WangJ.et al., “A review of deep learning on medical image analysis,” Mobile Networks Appl. 25(1), 351–380 (2020).10.1007/s11036-020-01672-7, WangJ.et al., “A review of deep learning on medical image analysis,” Mobile Networks Appl. 25(1), 351–380 (2020).10.1007/s11036-020-01672-7
-
(Shafiq-ul-HassanM.et al., “Accounting for reconstruction kernel-induced variability in CT radiomic features using noise power spectra,” J. Med. Imaging 5(1), 011013 (2017).10.1117/1.JMI.5.1.011013)
Shafiq-ul-HassanM.et al., “Accounting for reconstruction kernel-induced variability in CT radiomic features using noise power spectra,” J. Med. Imaging 5(1), 011013 (2017).10.1117/1.JMI.5.1.011013Shafiq-ul-HassanM.et al., “Accounting for reconstruction kernel-induced variability in CT radiomic features using noise power spectra,” J. Med. Imaging 5(1), 011013 (2017).10.1117/1.JMI.5.1.011013, Shafiq-ul-HassanM.et al., “Accounting for reconstruction kernel-induced variability in CT radiomic features using noise power spectra,” J. Med. Imaging 5(1), 011013 (2017).10.1117/1.JMI.5.1.011013
-
(LeithnerD.et al., “Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results,” Breast Cancer Res. 21(1), 106 (2019).10.1186/s13058-019-1187-z31514736)
LeithnerD.et al., “Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results,” Breast Cancer Res. 21(1), 106 (2019).10.1186/s13058-019-1187-z31514736LeithnerD.et al., “Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results,” Breast Cancer Res. 21(1), 106 (2019).10.1186/s13058-019-1187-z31514736, LeithnerD.et al., “Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results,” Breast Cancer Res. 21(1), 106 (2019).10.1186/s13058-019-1187-z31514736
-
Yajun Li, Lin Lu, Manjun Xiao, L. Dercle, Yue Huang, Zishu Zhang, L. Schwartz, Dai-qiang Li, Binsheng Zhao (2018)
CT Slice Thickness and Convolution Kernel Affect Performance of a Radiomic Model for Predicting EGFR Status in Non-Small Cell Lung Cancer: A Preliminary StudyScientific Reports, 8
-
(SmedleyN. F.HsuW., “Using deep neural networks for radiogenomic analysis,” in IEEE 15th Int. Symp. Biomed. Imaging, IEEE (2018).10.1109/ISBI.2018.8363864)
SmedleyN. F.HsuW., “Using deep neural networks for radiogenomic analysis,” in IEEE 15th Int. Symp. Biomed. Imaging, IEEE (2018).10.1109/ISBI.2018.8363864SmedleyN. F.HsuW., “Using deep neural networks for radiogenomic analysis,” in IEEE 15th Int. Symp. Biomed. Imaging, IEEE (2018).10.1109/ISBI.2018.8363864, SmedleyN. F.HsuW., “Using deep neural networks for radiogenomic analysis,” in IEEE 15th Int. Symp. Biomed. Imaging, IEEE (2018).10.1109/ISBI.2018.8363864
-
D. Leithner, J. Horvat, M. Marino, M. Marino, Blanca Bernard-Davila, M. Jochelson, R. Ochoa-Albíztegui, Danny Martinez, E. Morris, S. Thakur, K. Pinker (2019)
Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial resultsBreast Cancer Research : BCR, 21
-
(WhitesideT. L., “The tumor microenvironment and its role in promoting tumor growth,” Oncogene 27(45), 5904–5912 (2008).10.1038/onc.2008.27118836471)
WhitesideT. L., “The tumor microenvironment and its role in promoting tumor growth,” Oncogene 27(45), 5904–5912 (2008).10.1038/onc.2008.27118836471WhitesideT. L., “The tumor microenvironment and its role in promoting tumor growth,” Oncogene 27(45), 5904–5912 (2008).10.1038/onc.2008.27118836471, WhitesideT. L., “The tumor microenvironment and its role in promoting tumor growth,” Oncogene 27(45), 5904–5912 (2008).10.1038/onc.2008.27118836471
-
M. McNitt-Gray, S. Napel, A. Jaggi, S. Mattonen, L. Hadjiiski, M. Muzi, D. Goldgof, Y. Balagurunathan, L. Pierce, Paul Kinahan, E. Jones, A. Nguyen, A. Virkud, H. Chan, N. Emaminejad, M. Wahi-Anwar, M. Daly, M. Abdalah, H. Yang, L. Lu, W. Lv, A. Rahmim, A. Gastounioti, Sarthak Pati, S. Bakas, D. Kontos, B. Zhao, Jayashree Kalpathy-Cramer, K. Farahani (2020)
Standardization in Quantitative Imaging: A Multicenter Comparison of Radiomic Features from Different Software Packages on Digital Reference Objects and Patient Data SetsTomography, 6
-
O. Gevaert, Jiajing Xu, Chuong Hoang, A. Leung, Yue Xu, A. Quon, D. Rubin, S. Napel, S. Plevritis (2012)
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.Radiology, 264 2
-
Joost Griethuysen, Andrey Fedorov, C. Parmar, A. Hosny, Nicole Aucoin, V. Narayan, R. Beets-Tan, J. Fillion-Robin, S. Pieper, H. Aerts (2017)
Computational Radiomics System to Decode the Radiographic Phenotype.Cancer research, 77 21
-
Jia Wu, Xiaoli Sun, Jeff Wang, Yi Cui, F. Kato, H. Shirato, D. Ikeda, Ruijiang Li (2017)
Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validationJournal of Magnetic Resonance Imaging, 46
-
(AlizadehA. A.et al., “Toward understanding and exploiting tumor heterogeneity,” Nat. Med. 21(8), 846 (2015).10.1038/nm.391526248267)
AlizadehA. A.et al., “Toward understanding and exploiting tumor heterogeneity,” Nat. Med. 21(8), 846 (2015).10.1038/nm.391526248267AlizadehA. A.et al., “Toward understanding and exploiting tumor heterogeneity,” Nat. Med. 21(8), 846 (2015).10.1038/nm.391526248267, AlizadehA. A.et al., “Toward understanding and exploiting tumor heterogeneity,” Nat. Med. 21(8), 846 (2015).10.1038/nm.391526248267
-
(2017)
prognostic impact of peri-tumoral fat,” Clin -
Jui-Sheng Hsu, Ming-Shyan Huang, Chiao‐Yun Chen, G. Liu, Ta‐Chih Liu, I. Chong, S. Chou, Chih-Jen Yang (2014)
Correlation Between EGFR Mutation Status and Computed Tomography Features in Patients With Advanced Pulmonary AdenocarcinomaJournal of Thoracic Imaging, 29
-
(2018)
detecting IDH and TP53 mutations based on multimodal MRI,” J -
(ChaddadA.et al., “Novel radiomic features based on joint intensity matrices for predicting glioblastoma patient survival time,” IEEE J. Biomed. Health. Inf. 23(2), 795–804 (2019).10.1109/JBHI.2018.2825027)
ChaddadA.et al., “Novel radiomic features based on joint intensity matrices for predicting glioblastoma patient survival time,” IEEE J. Biomed. Health. Inf. 23(2), 795–804 (2019).10.1109/JBHI.2018.2825027ChaddadA.et al., “Novel radiomic features based on joint intensity matrices for predicting glioblastoma patient survival time,” IEEE J. Biomed. Health. Inf. 23(2), 795–804 (2019).10.1109/JBHI.2018.2825027, ChaddadA.et al., “Novel radiomic features based on joint intensity matrices for predicting glioblastoma patient survival time,” IEEE J. Biomed. Health. Inf. 23(2), 795–804 (2019).10.1109/JBHI.2018.2825027
-
(ClarkeL. P.et al., “The quantitative imaging network: NCI’s historical perspective and planned goals,” Transl. Oncol. 7(1), 1 (2014).10.1593/tlo.1383224772201)
ClarkeL. P.et al., “The quantitative imaging network: NCI’s historical perspective and planned goals,” Transl. Oncol. 7(1), 1 (2014).10.1593/tlo.1383224772201ClarkeL. P.et al., “The quantitative imaging network: NCI’s historical perspective and planned goals,” Transl. Oncol. 7(1), 1 (2014).10.1593/tlo.1383224772201, ClarkeL. P.et al., “The quantitative imaging network: NCI’s historical perspective and planned goals,” Transl. Oncol. 7(1), 1 (2014).10.1593/tlo.1383224772201
-
(JiangM.et al., “Assessing PD-L1 expression level by radiomic features from PET/CT in nonsmall cell lung cancer patients: an initial result,” Acad. Radiol. 27(2), 171–179 (2020).10.1016/j.acra.2019.04.01631147234)
JiangM.et al., “Assessing PD-L1 expression level by radiomic features from PET/CT in nonsmall cell lung cancer patients: an initial result,” Acad. Radiol. 27(2), 171–179 (2020).10.1016/j.acra.2019.04.01631147234JiangM.et al., “Assessing PD-L1 expression level by radiomic features from PET/CT in nonsmall cell lung cancer patients: an initial result,” Acad. Radiol. 27(2), 171–179 (2020).10.1016/j.acra.2019.04.01631147234, JiangM.et al., “Assessing PD-L1 expression level by radiomic features from PET/CT in nonsmall cell lung cancer patients: an initial result,” Acad. Radiol. 27(2), 171–179 (2020).10.1016/j.acra.2019.04.01631147234
-
(NishinoM.et al., “Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib,” Acad. Radiol. 23(3), 329–336 (2016).10.1016/j.acra.2015.11.00526776293)
NishinoM.et al., “Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib,” Acad. Radiol. 23(3), 329–336 (2016).10.1016/j.acra.2015.11.00526776293NishinoM.et al., “Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib,” Acad. Radiol. 23(3), 329–336 (2016).10.1016/j.acra.2015.11.00526776293, NishinoM.et al., “Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib,” Acad. Radiol. 23(3), 329–336 (2016).10.1016/j.acra.2015.11.00526776293
-
(2019)
initial results,” Breast Cancer Res -
(MeyerM.et al., “Reproducibility of CT radiomic features within the same patient: influence of radiation dose and CT reconstruction settings,” Radiology 293(3), 583–591 (2019).RADLAX0033-841910.1148/radiol.201919092831573400)
MeyerM.et al., “Reproducibility of CT radiomic features within the same patient: influence of radiation dose and CT reconstruction settings,” Radiology 293(3), 583–591 (2019).RADLAX0033-841910.1148/radiol.201919092831573400MeyerM.et al., “Reproducibility of CT radiomic features within the same patient: influence of radiation dose and CT reconstruction settings,” Radiology 293(3), 583–591 (2019).RADLAX0033-841910.1148/radiol.201919092831573400, MeyerM.et al., “Reproducibility of CT radiomic features within the same patient: influence of radiation dose and CT reconstruction settings,” Radiology 293(3), 583–591 (2019).RADLAX0033-841910.1148/radiol.201919092831573400
-
A. Chaddad, P. Daniel, Christian Desrosiers, M. Toews, B. Abdulkarim (2019)
Novel Radiomic Features Based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival TimeIEEE Journal of Biomedical and Health Informatics, 23
-
R. Vaidyanathan, Ren Soon, Pan Zhang, Kuan Jiang, C. Lim (2018)
Cancer diagnosis: from tumor to liquid biopsy and beyond.Lab on a chip, 19 1
-
(2017)
model discovery and external validation,” J -
(2018)
a survey,” Pattern Recognit -
(2010)
causes and consequences,” Biochim -
(VelazquezE. R.et al., “Somatic mutations drive distinct imaging phenotypes in lung cancer,” Cancer Res. 77(14), 3922–3930 (2017).10.1158/0008-5472.CAN-17-012228566328)
VelazquezE. R.et al., “Somatic mutations drive distinct imaging phenotypes in lung cancer,” Cancer Res. 77(14), 3922–3930 (2017).10.1158/0008-5472.CAN-17-012228566328VelazquezE. R.et al., “Somatic mutations drive distinct imaging phenotypes in lung cancer,” Cancer Res. 77(14), 3922–3930 (2017).10.1158/0008-5472.CAN-17-012228566328, VelazquezE. R.et al., “Somatic mutations drive distinct imaging phenotypes in lung cancer,” Cancer Res. 77(14), 3922–3930 (2017).10.1158/0008-5472.CAN-17-012228566328
-
(MazurowskiM. A., “Radiogenomics: what it is and why it is important,” J. Am. Coll. Radiol. 12(8), 862–866 (2015).10.1016/j.jacr.2015.04.01926250979)
MazurowskiM. A., “Radiogenomics: what it is and why it is important,” J. Am. Coll. Radiol. 12(8), 862–866 (2015).10.1016/j.jacr.2015.04.01926250979MazurowskiM. A., “Radiogenomics: what it is and why it is important,” J. Am. Coll. Radiol. 12(8), 862–866 (2015).10.1016/j.jacr.2015.04.01926250979, MazurowskiM. A., “Radiogenomics: what it is and why it is important,” J. Am. Coll. Radiol. 12(8), 862–866 (2015).10.1016/j.jacr.2015.04.01926250979
-
P. Zinn, S. Singh, Aikaterini Kotrotsou, Faramak Zandi, Ginu Thomas, M. Hatami, M. Luedi, A. Elakkad, Islam Hassan, J. Gumin, E. Sulman, F. Lang, R. Colen (2016)
139 Clinically Applicable and Biologically Validated MRI Radiomic Test Method Predicts Glioblastoma Genomic Landscape and Survival.Neurosurgery
-
(AlgoharyA.et al., “Combination of peri-tumoral and intra-tumoral radiomic features on bi-parametric MRI accurately stratifies prostate cancer risk: a multi-site study,” Cancers 12(8), 2200 (2020).10.3390/cancers12082200)
AlgoharyA.et al., “Combination of peri-tumoral and intra-tumoral radiomic features on bi-parametric MRI accurately stratifies prostate cancer risk: a multi-site study,” Cancers 12(8), 2200 (2020).10.3390/cancers12082200AlgoharyA.et al., “Combination of peri-tumoral and intra-tumoral radiomic features on bi-parametric MRI accurately stratifies prostate cancer risk: a multi-site study,” Cancers 12(8), 2200 (2020).10.3390/cancers12082200, AlgoharyA.et al., “Combination of peri-tumoral and intra-tumoral radiomic features on bi-parametric MRI accurately stratifies prostate cancer risk: a multi-site study,” Cancers 12(8), 2200 (2020).10.3390/cancers12082200
-
(2017)
histopathologic characteristics, response to neoadjuvant chemotherapy, and prognosis,” Sci -
(Van GriethuysenJ. J. M.et al., “Computational radiomics system to decode the radiographic phenotype,” Cancer Res. 77(21), e104–e107 (2017).10.1158/0008-5472.CAN-17-033929092951)
Van GriethuysenJ. J. M.et al., “Computational radiomics system to decode the radiographic phenotype,” Cancer Res. 77(21), e104–e107 (2017).10.1158/0008-5472.CAN-17-033929092951Van GriethuysenJ. J. M.et al., “Computational radiomics system to decode the radiographic phenotype,” Cancer Res. 77(21), e104–e107 (2017).10.1158/0008-5472.CAN-17-033929092951, Van GriethuysenJ. J. M.et al., “Computational radiomics system to decode the radiographic phenotype,” Cancer Res. 77(21), e104–e107 (2017).10.1158/0008-5472.CAN-17-033929092951
-
(WangJ. J.LeiK. F.HanF., “Tumor microenvironment: recent advances in various cancer treatments,” Eur. Rev. Med. Pharmacol. Sci. 22, 3855–3864 (2018).10.26355/eurrev_201806_1527029949179)
WangJ. J.LeiK. F.HanF., “Tumor microenvironment: recent advances in various cancer treatments,” Eur. Rev. Med. Pharmacol. Sci. 22, 3855–3864 (2018).10.26355/eurrev_201806_1527029949179WangJ. J.LeiK. F.HanF., “Tumor microenvironment: recent advances in various cancer treatments,” Eur. Rev. Med. Pharmacol. Sci. 22, 3855–3864 (2018).10.26355/eurrev_201806_1527029949179, WangJ. J.LeiK. F.HanF., “Tumor microenvironment: recent advances in various cancer treatments,” Eur. Rev. Med. Pharmacol. Sci. 22, 3855–3864 (2018).10.26355/eurrev_201806_1527029949179
-
(YushkevichP. A.GaoY.GerigG., “ITK-SNAP: an interactive tool for semi-automatic segmentation of multi-modality biomedical images,” in 38th Annu. Int. Conf. IEEE Eng. Med. and Biol. Soc., IEEE (2016).10.1109/EMBC.2016.7591443)
YushkevichP. A.GaoY.GerigG., “ITK-SNAP: an interactive tool for semi-automatic segmentation of multi-modality biomedical images,” in 38th Annu. Int. Conf. IEEE Eng. Med. and Biol. Soc., IEEE (2016).10.1109/EMBC.2016.7591443YushkevichP. A.GaoY.GerigG., “ITK-SNAP: an interactive tool for semi-automatic segmentation of multi-modality biomedical images,” in 38th Annu. Int. Conf. IEEE Eng. Med. and Biol. Soc., IEEE (2016).10.1109/EMBC.2016.7591443, YushkevichP. A.GaoY.GerigG., “ITK-SNAP: an interactive tool for semi-automatic segmentation of multi-modality biomedical images,” in 38th Annu. Int. Conf. IEEE Eng. Med. and Biol. Soc., IEEE (2016).10.1109/EMBC.2016.7591443
-
(AshrafA. B.et al., “Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles,” Radiology 272(2), 374–384 (2014).RADLAX0033-841910.1148/radiol.1413137524702725)
AshrafA. B.et al., “Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles,” Radiology 272(2), 374–384 (2014).RADLAX0033-841910.1148/radiol.1413137524702725AshrafA. B.et al., “Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles,” Radiology 272(2), 374–384 (2014).RADLAX0033-841910.1148/radiol.1413137524702725, AshrafA. B.et al., “Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles,” Radiology 272(2), 374–384 (2014).RADLAX0033-841910.1148/radiol.1413137524702725
-
Wenting Tu, Guangyuan Sun, L. Fan, Yun Wang, Yi Xia, Y. Guan, Qiong Li, Di Zhang, Shiyuan Liu, Zhaobin Li (2019)
Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.Lung cancer, 132
-
J. Obeid, Radka Stoyanova, Deukwoo Kwon, M. Patel, Kyle Padgett, Joyce Slingerland, C. Takita, Noam Alperin, Monica Yepes, Youssef Zeidan (2017)
Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fatClinical and Translational Oncology, 19
-
(BucklerA. J.et al., “A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging,” Radiology 258(3), 906–914 (2011).RADLAX0033-841910.1148/radiol.1010079921339352)
BucklerA. J.et al., “A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging,” Radiology 258(3), 906–914 (2011).RADLAX0033-841910.1148/radiol.1010079921339352BucklerA. J.et al., “A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging,” Radiology 258(3), 906–914 (2011).RADLAX0033-841910.1148/radiol.1010079921339352, BucklerA. J.et al., “A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging,” Radiology 258(3), 906–914 (2011).RADLAX0033-841910.1148/radiol.1010079921339352
-
(GerR. B.et al., “Effects of alterations in positron emission tomography imaging parameters on radiomics features,” PLoS One 14(9), e0221877 (2019).10.1371/journal.pone.022187731487307)
GerR. B.et al., “Effects of alterations in positron emission tomography imaging parameters on radiomics features,” PLoS One 14(9), e0221877 (2019).10.1371/journal.pone.022187731487307GerR. B.et al., “Effects of alterations in positron emission tomography imaging parameters on radiomics features,” PLoS One 14(9), e0221877 (2019).10.1371/journal.pone.022187731487307, GerR. B.et al., “Effects of alterations in positron emission tomography imaging parameters on radiomics features,” PLoS One 14(9), e0221877 (2019).10.1371/journal.pone.022187731487307
-
(RutmanA. M.KuoM. D., “Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging,” Eur. J. Radiol. 70(2), 232–241 (2009).10.1016/j.ejrad.2009.01.05019303233)
RutmanA. M.KuoM. D., “Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging,” Eur. J. Radiol. 70(2), 232–241 (2009).10.1016/j.ejrad.2009.01.05019303233RutmanA. M.KuoM. D., “Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging,” Eur. J. Radiol. 70(2), 232–241 (2009).10.1016/j.ejrad.2009.01.05019303233, RutmanA. M.KuoM. D., “Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging,” Eur. J. Radiol. 70(2), 232–241 (2009).10.1016/j.ejrad.2009.01.05019303233
-
L. Ding, M. Wendl, D. Koboldt, E. Mardis (2010)
Analysis of next-generation genomic data in cancer: accomplishments and challenges.Human molecular genetics, 19 R2
-
Ash Alizadeh, Victoria Aranda, A. Bardelli, C. Blanpain, C. Bock, C. Borowski, C. Caldas, A. Califano, Michael Doherty, Markus Elsner, M. Esteller, R. Fitzgerald, J. Korbel, P. Lichter, C. Mason, N. Navin, D. Pe’er, K. Polyak, C. Roberts, L. Siu, A. Snyder, Hannah Stower, C. Swanton, R. Verhaak, J. Zenklusen, J. Zuber, J. Zucman‐Rossi (2015)
Toward understanding and exploiting tumor heterogeneityNature Medicine, 21
-
(McNitt-GrayM.et al., “Standardization in quantitative imaging: a multicenter comparison of radiomic features from different software packages on digital reference objects and patient data sets,” Tomography 6(2), 118 (2020).10.18383/j.tom.2019.0003132548288)
McNitt-GrayM.et al., “Standardization in quantitative imaging: a multicenter comparison of radiomic features from different software packages on digital reference objects and patient data sets,” Tomography 6(2), 118 (2020).10.18383/j.tom.2019.0003132548288McNitt-GrayM.et al., “Standardization in quantitative imaging: a multicenter comparison of radiomic features from different software packages on digital reference objects and patient data sets,” Tomography 6(2), 118 (2020).10.18383/j.tom.2019.0003132548288, McNitt-GrayM.et al., “Standardization in quantitative imaging: a multicenter comparison of radiomic features from different software packages on digital reference objects and patient data sets,” Tomography 6(2), 118 (2020).10.18383/j.tom.2019.0003132548288
-
Saima Rathore, H. Akbari, Martin Rozycki, K. Abdullah, M. Nasrallah, Zev Binder, R. Davuluri, R. Lustig, N. Dahmane, M. Bilello, D. O’Rourke, C. Davatzikos (2018)
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1Scientific Reports, 8
-
L. J. Grimm, J. Zhang, M. A. Mazurowski (2015)
Computational approach to radiogenomics of breast cancer: luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms, 42
-
Binsheng Zhao, Yongqiang Tan, W. Tsai, Jing Qi, C. Xie, Lin Lu, L. Schwartz (2016)
Reproducibility of radiomics for deciphering tumor phenotype with imagingScientific Reports, 6
-
(ZinnP. O.et al., “139 clinically applicable and biologically validated MRI radiomic test method predicts glioblastoma genomic landscape and survival,” Neurosurgery 63(CN_suppl_1), 156–157 (2016).10.1227/01.neu.0000489709.98960.e1)
ZinnP. O.et al., “139 clinically applicable and biologically validated MRI radiomic test method predicts glioblastoma genomic landscape and survival,” Neurosurgery 63(CN_suppl_1), 156–157 (2016).10.1227/01.neu.0000489709.98960.e1ZinnP. O.et al., “139 clinically applicable and biologically validated MRI radiomic test method predicts glioblastoma genomic landscape and survival,” Neurosurgery 63(CN_suppl_1), 156–157 (2016).10.1227/01.neu.0000489709.98960.e1, ZinnP. O.et al., “139 clinically applicable and biologically validated MRI radiomic test method predicts glioblastoma genomic landscape and survival,” Neurosurgery 63(CN_suppl_1), 156–157 (2016).10.1227/01.neu.0000489709.98960.e1
-
K. Shin, W. Yang (2015)
Identification of Intrinsic Imaging Phenotypes for Breast Cancer Tumors: Preliminary Associations with Gene Expression ProfilesBreast Diseases: A Year Book Quarterly, 26
-
(LambinP.et al., “Radiomics: extracting more information from medical images using advanced feature analysis,” Eur. J. Cancer 48(4), 441–446 (2012).10.1016/j.ejca.2011.11.03622257792)
LambinP.et al., “Radiomics: extracting more information from medical images using advanced feature analysis,” Eur. J. Cancer 48(4), 441–446 (2012).10.1016/j.ejca.2011.11.03622257792LambinP.et al., “Radiomics: extracting more information from medical images using advanced feature analysis,” Eur. J. Cancer 48(4), 441–446 (2012).10.1016/j.ejca.2011.11.03622257792, LambinP.et al., “Radiomics: extracting more information from medical images using advanced feature analysis,” Eur. J. Cancer 48(4), 441–446 (2012).10.1016/j.ejca.2011.11.03622257792
-
(YehA. C.et al., “Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling,” Cancer Imaging 19(1), 48 (2019).10.1186/s40644-019-0233-531307537)
YehA. C.et al., “Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling,” Cancer Imaging 19(1), 48 (2019).10.1186/s40644-019-0233-531307537YehA. C.et al., “Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling,” Cancer Imaging 19(1), 48 (2019).10.1186/s40644-019-0233-531307537, YehA. C.et al., “Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling,” Cancer Imaging 19(1), 48 (2019).10.1186/s40644-019-0233-531307537
-
T. Whiteside (2008)
The tumor microenvironment and its role in promoting tumor growthOncogene, 27
-
(RathoreS.et al., “Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1,” Sci. Rep. 8(1), 5087 (2018).10.1038/s41598-018-22739-229572492)
RathoreS.et al., “Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1,” Sci. Rep. 8(1), 5087 (2018).10.1038/s41598-018-22739-229572492RathoreS.et al., “Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1,” Sci. Rep. 8(1), 5087 (2018).10.1038/s41598-018-22739-229572492, RathoreS.et al., “Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1,” Sci. Rep. 8(1), 5087 (2018).10.1038/s41598-018-22739-229572492
-
(BodalalZ.et al., “Radiogenomics: bridging imaging and genomics,” Abdom. Radiol. 44(6), 1960–1984 (2019).10.1007/s00261-019-02028-w)
BodalalZ.et al., “Radiogenomics: bridging imaging and genomics,” Abdom. Radiol. 44(6), 1960–1984 (2019).10.1007/s00261-019-02028-wBodalalZ.et al., “Radiogenomics: bridging imaging and genomics,” Abdom. Radiol. 44(6), 1960–1984 (2019).10.1007/s00261-019-02028-w, BodalalZ.et al., “Radiogenomics: bridging imaging and genomics,” Abdom. Radiol. 44(6), 1960–1984 (2019).10.1007/s00261-019-02028-w
-
M. Kuo, N. Jamshidi (2014)
Behind the numbers: Decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations.Radiology, 270 2
-
(ZinnP. O.et al., “Distinct radiomic phenotypes define glioblastoma TP53-PTEN-EGFR mutational landscape,” Neurosurgery 64(CN_suppl_1), 203–210 (2017).10.1093/neuros/nyx31628899058)
ZinnP. O.et al., “Distinct radiomic phenotypes define glioblastoma TP53-PTEN-EGFR mutational landscape,” Neurosurgery 64(CN_suppl_1), 203–210 (2017).10.1093/neuros/nyx31628899058ZinnP. O.et al., “Distinct radiomic phenotypes define glioblastoma TP53-PTEN-EGFR mutational landscape,” Neurosurgery 64(CN_suppl_1), 203–210 (2017).10.1093/neuros/nyx31628899058, ZinnP. O.et al., “Distinct radiomic phenotypes define glioblastoma TP53-PTEN-EGFR mutational landscape,” Neurosurgery 64(CN_suppl_1), 203–210 (2017).10.1093/neuros/nyx31628899058
-
D. Mackin, R. Ger, Cristina Dodge, X. Fave, P. Chi, L. Zhang, Jinzhong Yang, S. Bache, Charles Dodge, A. Jones, L. Court (2018)
Effect of tube current on computed tomography radiomic featuresScientific Reports, 8
-
Mu Zhou, A. Leung, Sebastian Echegaray, A. Gentles, J. Shrager, K. Jensen, G. Berry, S. Plevritis, D. Rubin, S. Napel, O. Gevaert (2017)
Non–Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic ImplicationsRadiology, 286
-
A. Rutman, M. Kuo (2009)
Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging.European journal of radiology, 70 2
-
Nova Smedley, William Hsu (2018)
Using deep neural networks for radiogenomic analysis2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018)
- Publisher
- SPIE
- Copyright
- © The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI.
- ISSN
- 2329-4302
- eISSN
- 2329-4310
- DOI
- 10.1117/1.jmi.8.3.031907
- Publisher site
- See Article on Publisher Site
Abstract
Abstract.The field of radiogenomics largely focuses on developing imaging surrogates for genomic signatures and integrating imaging, genomic, and molecular data to develop combined personalized biomarkers for characterizing various diseases. Our study aims to highlight the current state-of-the-art and the role of radiogenomics in cancer research, focusing mainly on solid tumors, and is broadly divided into four sections. The first section reviews representative studies that establish the biologic basis of radiomic signatures using gene expression and molecular profiling information. The second section includes studies that aim to non-invasively predict molecular subtypes of tumors using radiomic signatures. The third section reviews studies that evaluate the potential to augment the performance of established prognostic signatures by combining complementary information encoded by radiomic and genomic signatures derived from cancer tumors. The fourth section includes studies that focus on ascertaining the biological significance of radiomic phenotypes. We conclude by discussing current challenges and opportunities in the field, such as the importance of coordination between imaging device manufacturers, regulatory organizations, health care providers, pharmaceutical companies, academic institutions, and physicians for the effective standardization of the results from radiogenomic signatures and for the potential use of these findings to improve precision care for cancer patients.
Journal
Journal of Medical Imaging – SPIE
Published: May 1, 2021
Keywords: radiogenomics; prognostic signatures; precision medicine; cancer research